Rapid weight loss from traditional approaches like caloric restriction and bariatric surgery is known to cause bone loss, raising an important question: how do newer GLP-1-based highly effective anti-obesity medications (HEAOMs) measure up? Researchers at the CU Anschutz Health and Wellness Center seek to uncover how the medications may affect bone health.
We asked lead researchers Seth Creasy, PhD, and Victoria Catenacci, MD, who recently received pilot funding on this topic, to share their insights in a brief Q&A